Impact of Respiratory Motion on the Quantification of Pediatric Hepatic Steatosis Using Two Different Ultrasonography Machines
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to investigate the effect of respiratory motion on hepatic steatosis quantification using ultrasound attenuation imaging (ATI) or ultrasound-guided attenuation parameter (UGAP) in pediatric patients. Materials and Methods: Pediatric patients (aged ≤18 years) who underwent liver ultrasonography (US) with ATI or UGAP between May 2022 and February 2023 were included retrospectively. Median, interquartile range (IQR), and IQR/median values were calculated in both free-breathing (FB) and breath-holding (BH) states. Subjects were divided into normal and fatty liver groups according to grayscale US. Wilcoxon signed rank test, intraclass correlation coefficient (ICC), and linear regression test were used. Results: A total of 83 patients (M:F=46:37, median age 10 years, range 6–17 years) was included, with 55 patients in the ATI group and 28 patients in the UGAP group. The measured values of ATI and UGAP were not significantly different between FB and BH. The ICC values between FB and BH states were 0.950 [95% confidence interval (CI) 0.916–0.971] for median ATI and 0.786 (95% CI 0.591–0.894) for median UGAP. FB and BH status did not significantly affect the median ATI and UGAP (p=0.852, 0.531, respectively). The IQR/median value showed a significant association with age only in the FB status of the normal group using ATI (β=-0.014, p=0.042). Conclusion: Respiratory motion does not significantly affect the measurement of ATI or UGAP. Median ATI value showed excellent agreement in FB and BH status, while UGAP showed good agreement. Younger age may affect measurement variability in FB status of the normal group using ATI.
Abstract
Purpose: This study aimed to investigate the effect of respiratory motion on hepatic steatosis quantification using ultrasound attenuation imaging (ATI) or ultrasound-guided attenuation parameter (UGAP) in pediatric patients. Materials and Methods: Pediatric patients (aged ≤18 years) who underwent liver ultrasonography (US) with ATI or UGAP between May 2022 and February 2023 were included retrospectively. Median, interquartile range (IQR), and IQR/median values were calculated in both free-breathing (FB) and breath-holding (BH) states. Subjects were divided into normal and fatty liver groups according to grayscale US. Wilcoxon signed rank test, intraclass correlation coefficient (ICC), and linear regression test were used. Results: A total of 83 patients (M:F=46:37, median age 10 years, range 6–17 years) was included, with 55 patients in the ATI group and 28 patients in the UGAP group. The measured values of ATI and UGAP were not significantly different between FB and BH. The ICC values between FB and BH states were 0.950 [95% confidence interval (CI) 0.916–0.971] for median ATI and 0.786 (95% CI 0.591–0.894) for median UGAP. FB and BH status did not significantly affect the median ATI and UGAP (p=0.852, 0.531, respectively). The IQR/median value showed a significant association with age only in the FB status of the normal group using ATI (β=-0.014, p=0.042). Conclusion: Respiratory motion does not significantly affect the measurement of ATI or UGAP. Median ATI value showed excellent agreement in FB and BH status, while UGAP showed good agreement. Younger age may affect measurement variability in FB status of the normal group using ATI.
참고문헌 (18)
- Song K, "Feasibility of ultrasound attenuation imaging for assessing pediatric hepatic steatosis", Biology(Basel), 11, pp.1087~ (2022)
- Welman CJ, "Hepatic steatosis : ultrasound assessment using attenuation imaging(ATI)with liver biopsy correlation", J Med Imaging Radiat Oncol, 67, pp.45~53 (2023)
- Zhang X, "Increasing prevalence of NAFLD", NASH among children, adolescents and young adults from 1990 to 2017 : a population-based observational study, 2021, pp.11, e042843~
- Nobili V, "NAFLD in children : new genes, new diagnostic modalities and new drugs", Nat Rev Gastroenterol Hepatol, 16, pp.517~530 (2019)
- Ferraioli G, "Quantification of liver fat content with ultrasound : a WFUMB position paper", Ultrasound Med Biol, 47, pp.2803~2820 (2021)
- Yoon H, "Attenuation coefficient measurement using a high-frequency(2–9 MHz)convex transducer for children including fatty liver", Ultrasound Med Biol, 48, pp.1070~1077 (2022)
- Bozic D, "Ultrasound methods for the assessment of liver steatosis : a critical appraisal", Diagnostics(Basel), 12, pp.2287~ (2022)
- Tada T, "Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis : new trends and role of ultrasonography", J Med Ultrason(2001), 47, pp.511~520 (2020)
- Kuroda H, "Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease", J Med Ultrason(2001), 48, pp.471~480 (2021)
- Jang JK, "Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis : a systematic review and meta-analysis of prospective studies", Ultrasonography, 41, pp.83~92 (2022)
- Kim PH, "Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis : correlation with the controlled attenuation parameter", Ultrasonography, 41, pp.761~769 (2022)
- Shin J, "Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard", BMC Pediatr, 19, pp.112~ (2019)
- Ferraioli G, "US attenuation for liver fat quantification : an AIUM-RSNA QIBA pulseecho quantitative ultrasound initiative", Radiology, 302, pp.495~506 (2022)
- Shin HJ, "Motion effects on the measurement of stiffness on ultrasound shear wave elastography : a moving liver fibrosis phantom study", Med Ultrason, 1, pp.14~20 (2018)
- Jung C, "Hepatic shear wave elastography in children under freebreathing and breath-hold conditions", Eur Radiol, 27, pp.5337~5343 (2017)
- Lee JH, "Impact of respiratory motion on liver stiffness measurements according to different shear wave elastography techniques and region of interest methods : a phantom study", Ultrasonography, 40, pp.103~114 (2021)
- Zhao Y, "Reproducibility of ultrasound-guided attenuation parameter(UGAP)to the noninvasive evaluation of hepatic steatosis", Sci Rep, 12, pp.2876~ (2022)
- Seo DM, "How many times should we repeat measurements of the ultrasoundguided attenuation parameter for evaluating hepatic steatosis?", Ultrasonography, 42, pp.227~237 (2023)